Holen Sie sich die Stockscreener-App
21.58
2.86%
0.60
Handel nachbörslich:
21.60
0.02
+0.09%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Enovis CAO Oliver Engert acquires $25,948 in company stock - Investing.com UK
Enovis CAO Oliver Engert acquires $25,948 in company stock By Investing.com - Investing.com South Africa
Enovis (ENOV) CAO Oliver Engert adds 1,200 shares in open-market buys - Stock Titan
Is Enovis (ENOV) Using Spinamic to Quietly Redefine Its Orthopedic Innovation Playbook? - simplywall.st
A Look at Enovis Corp (ENOV) After 3.2% Gain -- GF Value $50.02 vs Price $21.80 - GuruFocus
Enovis stock hits 52-week low at 20.79 USD By Investing.com - Investing.com Nigeria
Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus
Enovis chief administrative officer Engert buys $23,000 in stock By Investing.com - Investing.com South Africa
Enovis chief administrative officer Engert buys $23,000 in stock - Investing.com
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in open market - Stock Titan
Medical Devices Specialty Stocks Q1 2026: Enovis Revenue Beat, Stock Down 12%News and Statistics - IndexBox
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & SuppliesSpecialty Stocks In Q1 - Yahoo Finance
Assessing Enovis (ENOV) Valuation After Recent Share Price Weakness - Yahoo Finance
Enovis stock hits 52-week low at 20.79 USD - Investing.com
CD&R Appoints Former Enovis CEO Matthew Trerotola as Operating Advisor - citybiz
CD&R Engages Former Enovis CEO as Operating Advisor — CD&R | Building Businesses Building Value - CD&R
Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock? - Insider Monkey
How The Investment Story For Enovis (ENOV) Is Evolving Without New Analyst Targets - Yahoo Finance
Is Enovis (ENOV) Using Spinamic To Quietly Redefine Its Orthopedics Innovation Edge? - Yahoo Finance
Enovis Launches Spinamic Hybrid Scoliosis Brace for Pediatric Patients - geneonline.com
Enovis launches hybrid scoliosis brace in U.S. market By Investing.com - Investing.com South Africa
Enovis launches hybrid scoliosis brace in U.S. market - Investing.com
Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining - GlobeNewswire
Why Enovis (ENOV) Is Up 9.6% After Beating Q1 Targets And Enhancing Incentive Plan Alignment - simplywall.st
A Look At Enovis (ENOV) Valuation As Shares Rebound And Long Term Returns Lag - simplywall.st
3 Reasons ENOV is Risky and 1 Stock to Buy Instead - Yahoo Finance UK
Top Enovis (ENOV) Competitors 2026 - MarketBeat
Enovis (ENOV): Revenue Beat, Margins Expand and Full-Year Outlook Maintained - Insider Monkey
Enovis Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Enovis Corp Stock Baskets - GuruFocus
Insider Buying: Oliver Engert Acquires Additional Shares of Enovis Corp (ENOV) - GuruFocus
Enovis chief administrative officer buys $22,220 in company stock By Investing.com - Investing.com South Africa
Enovis chief administrative officer buys $22,220 in company stock - Investing.com
Enovis (ENOV) Chief Administrative Officer buys 1,000 shares in open market - Stock Titan
Enovis Corp stock hits 52-week low at $20.96 By Investing.com - Investing.com Canada
Enovis Corp stock hits 52-week low at $20.96 - Investing.com
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now? - AOL.com
What's Driving the Recent Buzz Around Enovis (ENOV) Stock - Kavout
Enovis (ENOV) Earnings Date and Reports 2026 - MarketBeat
Enovis Corporation (ENOV) Holds Steady Near Support as Consolidation ContinuesETF Creation Redemption - thelegaladvocate.com
Enovis Corporation (ENOV) Sinks 7.15%: Assessing Support Levels and Potential ReversalMA Crossover - thelegaladvocate.com
Earnings Preview: Enovis Corp to Report Financial Results Pre-market on May 07 - Moomoo
A Look At Enovis (ENOV) Valuation After ESOP Shelf Registration For Up To 3,650,000 Shares - simplywall.st
1.21%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):